COLUMBIA, Md., Nov 06, 2007 /PRNewswire-FirstCall via COMTEX/ -- Martek Biosciences, a DHA omega-3 market leader, announced today that Parmalat Australia Ltd. has launched two new product lines featuring life'sDHA(TM), Martek's patented and vegetarian form of DHA omega-3. In March 2007, Parmalat Australia launched its first product featuring life'sDHA(TM), Vaalia My First Yoghurt for infant brain and eye health. Now Vaalia Low Fat Yoghurt and Vaalia Yoghurt for Toddlers join the life'sDHA(TM) offerings from Parmalat Australia.
Vaalia Low Fat Yoghurt is available in two flavors and features life'sDHA(TM) for adult brain, eye and heart health. Vaalia Yoghurt for Toddlers is available in two flavors and features life'sDHA(TM) for toddler brain, eye, and nervous system development. Both products are now available in major supermarket chains throughout Australia.
Parmalat Australia is a wholly owned subsidiary of Parmalat SpA, an Italian-based global dairy company with major operations in Europe, Latin America, North America and Australia. Its worldwide operations include almost 140 production centers and more than 36,000 employees.
In Australia, Martek is represented by distributor VILCO PTY LTD, Australia, to maximize the availability of life'sDHA(TM) in food and beverages.
"These product launches reflect the continued expansion of life'sDHA(TM) in international markets," said Joe Buron, vice president of sales and marketing for Martek Biosciences. "We are pleased to be working with Parmalat Australia, one of Australia's leaders in healthy nutrition, to make the benefits of life'sDHA(TM) available to consumers of all ages, from babies to adults."
DHA (docosahexaenoic acid) omega-3 is a long-chain omega-3 fatty acid that serves as a primary building block for the brain and the eyes and supports brain, eye and cardiovascular health throughout life. There is a large and growing body of scientific evidence demonstrating that people of all ages, from infants to aging adults, benefit from an adequate supply of DHA omega-3 in their diets. Scientific reviews have noted the importance of DHA omega-3 in proper brain and eye function, and there are studies currently underway to investigate its role in decreasing the prevalence of certain neurological disorders.
Martek's life'sDHA(TM) is unique in the market because it is derived from a sustainable and vegetarian source. Made from microalgae under tightly controlled manufacturing conditions, life'sDHA(TM) is free of oceanic contaminants that may be present in certain fish or fish oils. Microalgae are the only vegetarian source of DHA omega-3, the key omega-3 for brain and eye development and function.
Martek Biosciences Corporation (MATK ) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA(TM), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com.
Sections of this release contain forward-looking statements. These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the company's filings with the Securities and Exchange Commission, including, but not limited to, the company's Form 10-K for the fiscal year ended October 31, 2006 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K.